Observational studyFrontiers in immunology2025
Additions of trastuzumab to preoperative chemotherapy or chemoimmunotherapy for patients with potentially resectable stage III to IV
Xuchen Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.